Hexylamine → HCID 10184226, compound
Reaction equation
[CH2:1]([NH2:7])[CH2:2][CH2:3][CH2:4][CH2:5][CH3:6].[Cl:8][C:9]1[CH:14]=[CH:13][C:12]([C:15]2[N:16]=[C:17]([C:30](OCC)=[O:31])[N:18]([CH2:28][CH3:29])[C:19]=2[C:20]2[CH:25]=[CH:24][C:23]([Cl:26])=[CH:22][C:21]=2[Cl:27])=[CH:11][CH:10]=1>>[CH2:1]([NH:7][C:30]([C:17]1[N:18]([CH2:28][CH3:29])[C:19]([C:20]2[CH:25]=[CH:24][C:23]([Cl:26])=[CH:22][C:21]=2[Cl:27])=[C:15]([C:12]2[CH:11]=[CH:10][C:9]([Cl:8])=[CH:14][CH:13]=2)[N:16]=1)=[O:31])[CH2:2][CH2:3][CH2:4][CH2:5][CH3:6]Participants
3
Procedure
Using essentially the same procedure as Example 42, Step C, but using neat hexylamine (2 mL), ethyl 4-(4-chlorophenyl)-5-(2,4-dichlorophenyl)-1-ethylimidazole-2-carboxylate (25 mg, 0.060 mmol) from Example 42, Step B was converted to the title compound after purification by Prep TLC (25% ethyl acetate in hexanes). HPLC/MS: 478 (M+1), 480 (M+3); Rt=5.23 min.
Sources & evidence
- ORD record
- ord-a5f4bf8b60b44c058abe5de022cee1bc
- Source dataset
- uspto-grants-2006_06
- Patent number
- US07057051B2
Reaction notes
Loading…